跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Flavocoxid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Flavocoxid
Approved
STANDARD
Flavocoxid
Amherst Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ca1fa9f9a7f759e9
Company
Amherst Laboratories Inc.
Type
Standard
Approval Details
Approval Id
ca1fa9f9a7f759e9
Drug Approval Philippines Name
Flavocoxid
Product Name
Flavocoxid
Registration Number
THPR-57
Brand Name
Flavocoxid
Generic Name
Scutellaria baicalensis (Baikal skullcap) Root Extract + Acacia catechu (Catechu) Heartwood Extract
Dosage Form
Capsule
Dosage Strength
Formulation: Each 500 mg capsule contains: Scutellaria baicalensis (Baikal skullcap) Root Extract................380 mg Acacia catechu (Catechu) Heartwood Extract.................50 mg
Manufacturer
Amherst Laboratories Inc.
Issuance Date
28 December 2021
Expiry Date
28 December 2026
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ca1fa9f9a7f759e9
Type
Standard
Back to Philippines FDA Approvals